A Phase II Study in Patients With Alopecia Areata

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a global Phase 2 study to evaluate the safety and effectiveness of an investigational study drug (called SHR0302) in adults with moderate to severe alopecia areata.
Epistemonikos ID: 52a8ee5ac7b81bf1b02da92cb03f6e0eec1f8984
First added on: May 07, 2024